Akero Therapeutics, Inc.

NASDAQ:AKRO

54.28 (USD) • At close June 6, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Omzet 000000.284000000000000000000000000
Kosten van de omzet 0000.0010.0010.0020.0050.0690.0680.0650.0660.0650.0640.0630.060.060.0610000000000000
Brutowinst 000-0.001-0.0010.282-0.005-0.069-0.068-0.065-0.066-0.065-0.064-0.063-0.06-0.06-0.0610000000000000
Brutowinstmarge 000000.993000000000000000000000000
Onderzoek- en ontwikkelingskosten 69.56769.29372.23255.32250.6553.39238.63427.98521.78718.3225.08721.36320.51427.71119.4723.97610.60225.70917.37913.0378.79113.13813.8855.964.0631.9831.2538.420.2260.68
Algemene en administratieve kosten 11.3158.7329.47110.4199.3048.4817.9817.6446.9667.111.0046.2315.5374.7284.8834.994.5264.0744.1593.4173.5883.0832.4241.6491.4490.9850.4740.2420.1950.28
Verkoop- en marketingkosten 000-0.001-0.001-0.002000000000000000000000000
Verkoop-, algemene en administratieve kosten 11.3158.7329.47110.4189.3038.4797.9817.6446.9667.111.0046.2315.5374.7284.8834.994.5264.0744.1593.4173.5883.0832.4241.6491.4490.9850.4740.2420.1950.28
Overige kosten 000-10.4180-16.6267.8445.4033.3792.7230.8730.24400.0150.0230.0330.0380.0720.1350.2470.4930.610.7550.3810.15-58.504-9.421-0.01100
Bedrijfskosten 80.88278.02581.70365.7459.95361.87146.61535.62928.75325.4236.09127.59426.05132.43924.35328.96615.12829.78321.53816.45412.37916.22116.3097.6095.5122.9681.7278.6620.4210.96
Bedrijfsresultaat -80.882-78.025-81.703-65.741-59.954-61.873-46.615-35.629-28.753-25.42-36.091-27.594-26.051-32.439-24.353-28.966-15.128-29.783-21.538-16.454-12.379-16.221-16.309-7.609-5.512-2.968-1.727-8.662-0.421-0.96
Bedrijfsresultaat ratio 00000-217.863000000000000000000000000
Totaal overige inkomsten en kosten netto 10.1578.0018.9989.7546.616.6876.9564.5462.9222.3610.5490.1910.0220.0150.0230.0330.0380.0720.1350.2470.4930.610.7550.3810.15-58.504-9.421-0.01100
Inkomen voor belasting -70.725-70.024-72.705-55.987-53.344-55.186-39.659-31.083-25.831-23.059-35.542-27.403-26.029-32.424-24.33-28.933-15.09-29.711-21.403-16.207-11.886-15.611-15.554-7.228-5.362-61.472-11.148-8.673-0.421-0.96
Inkomen voor belasting ratio 00000-194.317000000000000000000000000
Belastingkosten 0000-0.042-12.5278.7326.26-2.465-2.574-0.5490.297-0.022-0.011-0.051-0.05-0.05-0.011-0.006-1.323-1.237-0.046-16.309-7.609-5.362-2.9680-8.662-0.4210
Nettowinst -70.725-70.024-72.705-55.987-53.344-55.186-39.659-31.083-23.366-20.485-34.993-27.403-26.007-32.424-24.33-28.933-15.09-29.711-21.403-16.207-11.886-15.611-15.554-7.228-5.362-61.472-11.148-8.673-0.421-1.026
Nettowinstmarge 00000-194.317000000000000000000000000
WPA (Winst Per Aandeel) -0.9-0.99-1.05-0.81-0.9-0.99-0.71-0.6-0.5-0.44-0.91-0.77-0.74-0.93-0.7-0.83-0.43-0.86-0.63-0.57-0.42-0.55-0.56-2.21-0.2-2.9-0.53-0.41-0.02-4.54
Verwaterde WPA -0.9-0.99-1.05-0.81-0.9-0.99-0.71-0.6-0.5-0.44-0.91-0.77-0.74-0.93-0.7-0.83-0.43-0.86-0.63-0.57-0.42-0.55-0.56-2.21-0.2-2.9-0.53-0.41-0.02-4.53
EBITDA -80.882-68.809-71.458-54.755-52.352-54.287-38.766-30.157-25.306-22.632-35.152-27.285-25.965-32.428-24.27-28.873-15.117-29.772-21.538-16.454-12.379-16.221-16.309-7.6090.15-2.968-11.148-0.081-0.421-0.066
EBITDA ratio 00000-191.151000000000000000000000000